-

Auragens Selected as Top Stem Cell Treatment Center Worldwide

Life Sciences Review Names Auragens Best in Class Following a Comprehensive Review of the Science, Biologics, Safety Profile, Medical Team, Patient Experience and Patient Outcomes

PANAMA CITY & LAS VEGAS--(BUSINESS WIRE)--Auragens, an established leader in Stem Cell research, development and treatment, has been singled out as the best facility for stem cell treatments, globally. A further recognition of their leadership in the field and their dedication to regenerative medicine.

“Stem cell therapy and regenerative medicine hold immense promise but the field remains vulnerable to misinformation… Auragens bridges that gap by anchoring its work in hard science, rigorous ethics, and irrefutable outcomes,” stated Life Sciences Review

Share

“While stem cell therapy and regenerative medicine hold immense promise, the field remains vulnerable to misinformation, pseudoscience and bad actors who exploit hope without ensuring safety or delivering results… Auragens bridges that gap by anchoring its work in hard science, rigorous ethics, and irrefutable outcomes,” stated Life Sciences Review.

Auragens set itself apart in the industry through its transparency and openness with more traditional healthcare practitioners and academia. By inviting numerous, well-respected third parties to their center to provide oversight, facilitate collaboration and innovation, and document without bias all patient outcomes, Auragens has greatly benefited from an interdisciplinary cohort of experts who are mission driven to improve the quality of life for their patients.

“A recognition such as this, is yet another reminder to the entire organization that our firm commitment to excellence, and to our patients, is seen and appreciated by our peers in other specialties,” said Auragens CEO Dr. Dan Briggs. “The field of stem cell treatments is rapidly expanding, and we appreciate Life Sciences Review’s awareness that a proactive approach must be taken to separate the truth from the fiction in medical care and patient options.”

Auragens has received numerous commendations and prestigious recognitions for their work in this field from awards to keynote presentations to published papers to best-selling books. But what has driven the success is the patient-centric focus on results. The core mission of changing the trust relationship between regenerative medicine and those who will benefit, establishing the standard of care and predictable outcomes that must become a requirement for all in the field. Being recognized for the quality of the treatments, through tireless scientific and medical work, is another powerful step in this continued evolution to benefit all mankind.

About Auragens – Auragens is the market leader in the field of stem cell treatments, research, and development. They operate their own laboratory onsite and are ISO certified while pursuing AABB accreditation and following all cGMP guidelines and FDA related regulations for safety. Treatments are provided at their private state-of-the-art facility in Panama City, Panama and spans the entire 48th floor of a Class A office building in the Beverly Hills of Panama City, known as Punta Pacifica. All science and medicine are overseen by a team of doctors hailing from universities such as Johns Hopkins, Stanford and Notre Dame among others. Published in numerous journals, recipient of Medical Researcher of the Year and Business of the Year, Auragens is leading in cutting edge Regenerative Medicine with a goal of making their treatments a Standard of Care and available to all in need.

For more information: http://www.Auragens.com email us: Info@Auragens.com or call us: +1-844-888-6717

Contacts

Info@Auragens.com
+1-844-888-6717

More News From Auragens

Independent Recognition Reinforces Auragens' Position as a Global Leader in Regenerative Medicine

LAS VEGAS & PANAMA CITY, Panama--(BUSINESS WIRE)--Auragens today announced it has been named Stem Cell Treatment Center of the Year 2026 by Life Sciences Review, becoming the first organization to receive the publication's highest distinction for two consecutive years. While the award recognizes excellence in patient care, it also reflects a broader transformation taking place within regenerative medicine—one in which scientific rigor, manufacturing quality, regulatory oversight, and integrated...

Auragens Achieves AABB Accreditation, Marking Major Milestone in Regenerative Medicine Quality and Patient Safety

LAS VEGAS & PANAMA CITY--(BUSINESS WIRE)--Auragens, a leading regenerative medicine and research institute, today announced that it has achieved accreditation from the Association for the Advancement of Blood & Biotherapies (AABB), a globally recognized organization known for establishing rigorous standards in cellular therapy, biologics, transfusion medicine, and related healthcare services. The accreditation represents a significant achievement for Auragens and reflects the organization's...

Dr. Dan Briggs of Auragens named Entrepreneur Of The Year® 2026 Pacific Southwest finalist by EY US

LAS VEGAS--(BUSINESS WIRE)--Dr. Dan Briggs, founder / CEO of Auragens, has been named a finalist for the Entrepreneur Of The Year 2026 Pacific Southwest Award by Ernst & Young LLP (EY US). Now in its 41st year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and uplifting communities. The program honors entrepreneurs whose innovations drive economic growth and help shape the f...
Back to Newsroom